Telomir Pharmaceuticals(NASDAQ:TELO) 
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. The company is headquartered in Baltimore, Maryland.
Founded: 2021
Sector: TECHNOLOGY
Industry: GENERAL
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.80
H 3.08
L 2.61
C 2.93
V 178,838
10EMA 2.93
20EMA 2.93
60EMA 2.93
120EMA 2.93
250EMA 2.93